Opioid Sparing Analgesia: Dexmedetomidine Versus Lidocaine for Intracranial Surgeries in Children

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Perioperative pain control is necessary in children as inadequate treatment may lead to progression of perception of pain and development of chronic pain in the future.

Anesthetists tend to adopt approach to perioperative control of pain by non-opioid drugs that mediate pain modulation. Its use as opioid sparing analgesia in different surgeries leading to mixed results.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Zagazig University
• Treatments: Dexmedetomidine; Lidocaine

Criteria

Inclusion Criteria:

• Age: 6-18 years old.

• Sex: both sexes.

• Physical status: American Society Of Anesthesiologist 1& II.

• Body Mass Index >5 th and < the 85th percentile for age.

• Type of operations: elective intracranial surgeries under general anesthesia.

• Duration of operation < 3 hours.

• Written informed consent from the parent of child

Exclusion Criteria:

• Altered mental state

• Unsuitability for extubation.

• Patients on beta blocker, alpha 2 agonist.

• Patients on pain killer or with known history of allergy to study drugs.

• Hepatic, renal, Cardiovascular and respiratory disease.

• The patient has the right to withdraw from the study at any time without any negative consequence on their medical or surgical treatment plan.